)

Pacira BioSciences (PCRX) investor relations material
Pacira BioSciences Q2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Executive summary
Achieved total Q2 2025 revenues of $181.1M, with strong execution across corporate, clinical, and commercial initiatives, supporting the five by 30 growth strategy and leadership in musculoskeletal pain.
EXPAREL and ZILRETTA drove growth, with over 3M patients treated annually and double-digit compounded annual product revenue growth.
Net loss for Q2 2025 was $4.8M, primarily due to higher operating expenses and one-time legal settlement costs; non-GAAP net income was $36.0M.
Strategic initiatives included the acquisition of GQ Bio Therapeutics, a co-promotion agreement with J&J MedTech for ZILRETTA, and a reduction in force to optimize manufacturing.
Repurchased 2.0M shares for $50M; ended Q2 with $445.9M in cash, pro forma $270M after debt repayment and royalty receipt.
Financial highlights
Q2 2025 revenues rose to $181.1M from $178.0M year-over-year; EXPAREL sales grew 4.4% to $142.9M, ZILRETTA up 2% to $31.3M, iovera° $5.6M.
Non-GAAP gross margin improved to 82% from 76% year-over-year; GAAP gross margin 77% (up from 75%).
Adjusted EBITDA for Q2 was $54.3M; adjusted EBITDA margin approximately 30% of revenue.
Operating expenses rose to $172.6M, driven by higher R&D and SG&A.
Cash and investments: $445.9M at quarter-end, pro forma $270M after debt repayment.
Outlook and guidance
2025 total revenue guidance narrowed to $730M–$750M (prior $725M–$765M); non-GAAP gross margin raised to 78–80% (prior 76–78%).
Non-GAAP R&D expense expected at $90M–$105M; SG&A at $290M–$320M; stock-based compensation $56M–$61M.
Continued investment in clinical programs, commercial expansion, and manufacturing enhancements for EXPAREL, ZILRETTA, and iovera°.
Expect sustainable earnings growth driven by sales, margin expansion, and share repurchases.
Next Pacira BioSciences earnings date

Next Pacira BioSciences earnings date

The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage